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Summary
Objective: To determine whether human osteoarthritic (OA) cartilage loses its ability to remain avascular when placed into the in-vivo model
of angiogenesis, the chick embryo chorio-allantoic membrane (CAM), and to determine specific changes that occur in the cartilage matrix
when the cartilage is exposed to an active vasculature.
Design: Articular cartilage from OA and non-OA joints was grafted onto the CAM for up to 5 days before fixing and processing for histological,
histochemical and immunological examination for specific changes in proteoglycan and collagen.
Results: OA cartilage, but not non-OA cartilage, showed invasion of its matrix by blood vessels from the CAM to various extents. Associated
with these blood vessels was a loss of staining for proteoglycans and cartilage specific glycosaminoglycans (GAG). A deposition of collagen
types I and X was also visualized around the invasive vessels.
Conclusions: OA cartilage loses or has already lost its ability to remain avascular when placed onto the chick CAM. Changes occur in the
matrix around the invasive blood vessels, specifically a loss of proteoglycan and GAG, and the deposition of new collagen types, notably I
and X. © 1999 OsteoArthritis Research Society International
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Osteoarthritis (OA) is a disease of complex etiology,1 often
considered to be a slowly progressive disorder occurring
late in life.2 The result of OA is a loss of the normal function
of the joint due to a breakdown of the articular cartilage.1
Macroscopically, OA appears focal.2–4 The cartilage loses
its normal glistening appearance, and yellow or brown
spots appear.4 The cartilage becomes frayed and/or fibril-
lated with penetrating fissures or clefts and there is loss
of cartilage tissue.5–8 As the severity of the disease
increases, there is cartilage erosion, often with eburnation,
and focal exposure of the subchondral bone.4,5,7 Changes
are also known to occur within the underlying subchondral
bone,9,10 including bony sclerosis, cyst and osteophyte
formation.2,6,11,12
One of the less recognized changes which occurs during
OA, is the violation of the tidemark between the subchon-
dral bone and articular cartilage by blood vessels.2 This
concept of neovascularization in OA cartilage is relatively
new.2,13 The avascular nature of articular cartilage is not
clearly understood although it is generally considered to be
a function of anti-angiogenic molecules within the tis-
sue.14,15 A specific angiogenic inhibitor, cartilage derived
inhibitor (CDI), has been isolated from cartilage, and has
been shown to inhibit the proliferation and migration of441capillary endothelial cells in-vitro, and angiogenesis
in-vivo.14
Cartilage vascularization is thought important in three
steps of OA pathology, the formation and growth of osteo-
phytes, the advancement of the underlying subchondral
bone and remodeling of the joint.16 The process of cartilage
vascularization is extremely complex and probably involves
cartilage mineralization, changes in protease activity and
changes in inhibition of proteases.15–17 It is also possible
that there is release of angiogenic factors encouraging
vascularization to occur, and indeed a very low molecular
weight substance (600 daltons) from cartilage, termed
endothelial cell stimulating angiogenic factor (ESAF), has
been described to stimulate vascularization, and also
to activate latent matrix metalloproteinases (MMP) in
cartilage.16
At the cellular level, normal cartilage shows only a very
low level of matrix biosynthesis.18 There is, however,
evidence to suggest that during OA, the chondrocytes
within articular cartilage respond to the disease by
mounting a biosynthetic response, considered to be an
attempt at repair.2,19,20 The use of radiolabelled precursors
of both collagen and proteoglycan have shown a new wave
of synthesis of these components by the damaged
tissue.3,19–24 A number of studies have also been per-
formed to investigate whether there is a change in the
phenotype of chondrocytes and/or a change in the ECM of
articular cartilage during OA.7,25–31 It has been shown that
significant alterations in the collagen expression of
chondrocytes does occur during OA,25,28–30 particularly
for a phenotypic switch of the chondrocytes to produce
the method of Scott and Dorling.
442 S. A. Fenwick et al.: Osteoarthritic cartilage vascularizationcollagen types I, III7,25,29,32 and X.26,28,30 Type I and III
collagen have been identified immunohistochemically in
OA articular cartilage in the pericellular matrix of some
chondrocytes,7,25 although biochemical analysis has dem-
onstrated that most of the collagen in OA cartilage is still
type II.33 Although levels of types I and III collagen in OA
cartilage may not be significant relative to the amount of
type II collagen,7 the minor differences are indicative of
important modifications in chondrocyte metabolism and the
collagen network during cartilage degeneration in OA.33
Cartilage mineralization and the formation of bone on
calcified cartilage are thought to be key phases during bone
remodeling in OA.34 Type X collagen is believed to function
during the calcification of cartilage during endochondral
ossification.35 The presence of type X collagen has been
shown in normal articular cartilage immunochemically at
the cartilage surface,28 and at the mRNA level in some
chondrocytes adjacent to the calcified cartilage layer.26 In
OA cartilage, type X collagen has been localized immuno-
chemically around chondrocyte clusters in fibrillated,
severely damaged OA cartilage in the upper and
middle zones, in hypertrophic cells28,30 and within the
chondrocytes of the calcified layer.26
The earliest and most prominent change in OA cartilage,
at the histological level is a progressive increase in the loss
of proteoglycans,20,23,24 shown by a moderate decrease in
metachromatic staining.2 The release of proteoglycan from
OA cartilage is believed to be greater than that from normal
cartilage.36 As the disease progresses, there is a progres-
sive loss of colour with the metachromatic stains, such
as alcian blue, and the orthochromatic stains, such as
safranin-O,2 which can be explained by the extensive
removal of aggrecan seen in severe OA.8
The role of neovascularization of articular cartilage in OA
has not been well studied, and little is known about the
changes that occur within the cartilage relating to cartilage
vascularization. We describe here the loss of avascularity
of human osteoarthritic articular cartilage when it is placed
into the in-vivo model of vascularization, the chick embryo
chorio-allantoic membrane, and show a loss of proteogly-
can and glycosaminoglycan, and a deposition of collagen
types I and X around the invasive vasculature.Materials and methods
HUMAN TISSUE HARVESTING
Human OA cartilage was obtained direct from theatre
after total knee replacement (TKR) from five male and four
female patients between the ages of 58 and 79. Non-OA
human cartilage was obtained from the ankle joint of a
female aged 67 undergoing above knee amputation and
from three femoral heads of three females aged 68, 71 and
77, undergoing hip replacement for fractured neck of femur.
Cartilage was taken from theatre and harvested asepti-
cally in a class 2 microbiological safety cabinet. The femo-
ral condyles of the OA knees were cut into thin strips with a
pair of bone cutters. The cartilage, taken from areas of
relatively healthy looking cartilage of at least 3 mm in
depth, was then carefully cut away from the subchondral
bone at the bone/cartilage interface with a scalpel to
maintain the full thickness of the cartilage. Slices of this
cartilage 1-mm thick were taken for use in CAM grafting
experiments. Slices of ankle and femoral head cartilage
were cut off with a scalpel as close to the underlying bone
as possible to maintain as full thickness of the cartilage aspossible. Histological observation did not show any evi-
dence of the calcified cartilage layer. Slices of 1-mm
thickness were again taken for use in CAM grafting
experiments.CAM GRAFTS
Fertilized White Leghorn chicken eggs were obtained
from a registered supplier and incubated in a humidified
incubator at 37°C. The eggs were windowed at 3 days to
check fertility, sealed with sellotape and returned to the
incubator until 10 days of age. The 1-mm thick slices of
cartilage were cut in half. One half was laid flat onto the
CAM of 10-day-old chick embryos, three pieces per CAM in
each of 12 eggs, and incubated at 37°C for 5 days. After the
incubation period, the grafts were removed, the excess
CAM tissue removed, and the grafts prepared for either
wax histology or cryosectioning. The second, ungrafted,
half was prepared directly for similar treatment.HISTOLOGY AND HISTOCHEMISTRY
Grafted and ungrafted cartilage was fixed in 10% neutral
buffered formalin for up to a week before processing for
wax histology and histochemistry. The grafted cartilage was
further trimmed of excess CAM tissue before processing.
Sections (7 ìm) were cut on a sledge microtome and
mounted on 3-aminopropyltriethoxy-silane (silane) (Sigma,
Poole) coated slides. Every fourth section was stained with
haemotoxylin and eosin for general morphology. A number
of other sections were stained with safranin-O (BDH) (0.5%
in 0.1M acetate buffer) to detect proteoglycans or with
alcian blue at critical electrolyte concentrations (CEC) of
0.7 M MgCl2 to detect cartilage specific GAG, according to
37CRYOSECTIONING
Grafted cartilage was excised and trimmed of excess
CAM tissue before embedding in Cryo-M-Bed (Bright) on a
piece of cork and snap frozen in liquid nitrogen. Non-
grafted cartilage was snap frozen in an identical manner.
Samples were stored at −80°C until ready for sectioning.
Sections were cut on a Bright cryostat model OTF with a
blade specifically designed for skeletal tissue. Sections
(7 ìm) were cut and mounted on clean silane (Sigma)
coated slides, before air-drying at room temperature for
60 min. The sections were then fixed in analytical grade
acetone (Fisher) for 10 min and air-dried before wrapping
in foil and storage at −20°C until ready for staining.IMMUNOSTAINING
Sections were brought to room temperature then
unwrapped and hydrated in TBS. After treatment with
testicular hyaluronidase (Type I-S, Sigma) 1 mg/ml in
acetate buffer (50 mM NaAc+2 mM NaCl) for 1 h, the
sections were rinsed in TBS and flooded with normal rabbit
serum (Serotec) diluted 1:5 with TBS for 10 min. Serum
was then removed but not rinsed, before addition of primary
antibody. The primary antibodies used were goat anti-
human type I collagen (Southern Biotechnologies), mouse
anti-type II collagen (CIICI, DSHB) and mouse anti-human
Osteoarthritis and Cartilage Vol. 7 No. 5 443Fig. 1. (a) OA cartilage and (b) healthy cartilage grafted onto the CAM of a 10 day old chick embryo for 4 days. Blood vessels and CAM tissue
can be seen growing over both pieces of cartilage (×10). (c indicates the cartilage, arrows indicate blood vessels within the overlying CAM,
the blurred edges in (a) are the egg shell).
(a)
(b)type X collagen (MB6, A kind gift from Dr A. Kwan,
University of Wales, Cardiff). Dilutions were made as rec-
ommended, 1:20 for type I , 1:5 for type II and 1:100 for
type X. All dilutions were made in TBS. Slides were
incubated for 1 h at room temperature, then rinsed in TBS
before addition of appropriate secondary antibody, either
rabbit anti-goat peroxidase conjugated secondary antibody,
or rabbit anti-mouse biotin conjugated antibody respect-
ively (Dako) at 1:200 dilution in TBS for 1 h at roomtemperature. Peroxidase-labeled sections were rinsed and
incubated in DAB/H2O2 solution (Sigma Fast DAB Tablets,
Sigma) for 3–5 min, rinsed again before counterstaining in
Mayers haemotoxylin, dehydration and mounting in DPX
(BDH). Biotin labeled sections were rinsed before addition
of ABComplex (Dako) for 20–30 min, rinsed again then
incubated with DAB (Sigma) for 3–5 min. Slides were
counterstained with haemotoxylin then dehydrated before
mounting in DPX mountant (BDH) and visualized on an
(a)Fig. 2. Invasion of OA cartilage by CAM tissue after being grafted onto the CAM (a) a cellular infiltrate with no indication of vessel formation,
(b) a line of cells and (c) an actual blood vessel (H&E ×100) (arrows indicate the invasive cells/vessel, t is the CAM tissue).
(b)
(c)
Osteoarthritis and Cartilage Vol. 7 No. 5 445Olympus BH2 light microscope. Negative controls had the
primary antibody omitted.Results
All OA tissue generally had lost the shiny hyaline look
associated with normal articular cartilage.2,4,6 The tissue
varied in thickness from approx. 1 mm to 3–4 mm. Only the
thicker pieces were used for grafting. During incubation on
the CAM, almost all pieces of cartilage, both OA and
non-OA, became at least partially enveloped in CAM tissue
containing blood vessels (Fig. 1). However, there was no
leakage of blood around the grafts. This is in contrast to
when chick embryonic long bone rudiment cartilage is
38grafted onto the CAM in an identical manner.HISTOLOGY AND HISTOCHEMISTRY
CAM grafted sections stained with H&E revealed that all
OA cartilage had become invaded by CAM derived cells to
varying extents. The invasive tissue appeared as either
groups of single cells, lines of cells or occasionally as a
proper lumen containing erythrocytes (Fig. 2). None of the
non-OA cartilage, despite becoming enveloped in CAM
tissue containing blood vessels, showed any vascular inva-
sion [Fig. 3(a)]. Invasion of the OA cartilage occurred
through the deep layers and possibly from the side of the
deep layers of the sections, it was never seen to occur
through the surface layers [Fig. 3(b)]. The majority of the
invasive cells were morphologically fibroblastic in nature
(see Fig. 1).
Histochemical staining with safranin-O showed a loss of
metachromatic staining around invasive vessels, indicating
a loss of proteoglycans [Fig. 4(a)]. Alcian blue at CEC of
0.7 M MgCl2 for cartilage specific GAG also showed a loss
of staining around invasive vessels [Fig. 4(b)]. Throughout
the rest of the cartilage in these sections, the staining for
both proteoglycan and GAG was extremely variable,
although generally the surface and upper layers had lost a
lot of their staining properties while the deep layers stained
relatively strongly. Non-OA cartilage stained uniformly
throughout except the very surface layer, which is known to
39have a low proteoglycan content.IMMUNOHISTOCHEMISTRY
Antibody staining was performed for collagen types I, II
and X on both CAM grafted and non-CAM grafted cartilage
to discern any effect that the CAM may have on the
collagen content of the matrix.TYPE I COLLAGEN
Type I collagen was localized to the surface layer of OA
cartilage [Fig. 5(a)], whether CAM grafted or not, although
some areas of the surface did not stain, most likely due to
previous erosion during the disease process. In CAM
grafted cartilage, the chondrocytes were negative for type I
collagen staining. When vascular invasion was clearly
seen, the edges of the invasive site stained very intensely
for type I collagen [Fig. 5(a) and (b)]. Non-CAM grafted OA
cartilage showed a number of chondrocytes at all depths
staining positively for type I collagen. Non-OA cartilage,
whether grafted or not had some surface staining, butgenerally, there was little other indication of any positive
staining.TYPE II COLLAGEN
When stained for type II collagen, CAM grafted and
non-CAM grafted non-OA cartilage showed identical
results. Two patterns of staining were seen similar to those
described previously.27,29,31 Some samples showed uni-
form staining throughout the cartilage while other samples
showed intense pericellular staining, with a lower intensity
in the interterritorial matrix, or a combination of the two [Fig.
6(a)]. The chondrocytes themselves stained negatively.
The chondrocytes in grafted and non-grafted OA cartilage
were also negative for type II collagen, although staining of
the matrix showed much variability. There was a tendency
towards pericellular staining [Fig. 6(b)]. In the grafted
cartilage, where invasion was visible, there was no lack of
staining intensity.TYPE X COLLAGEN
Unlike the staining for collagen types I and II, where
there was very little variation in the staining properties
between different samples, staining for type X collagen
showed a number of patterns which has been described
previously.30 All samples showed positive staining of the
chondrocytes to varying extents [Fig. 7(a)]. Non-grafted
non-OA cartilage generally showed a positive result in all
chondrocytes throughout the sections, although the matrix
showed no evidence of positive staining except in the
occasional section where there was faint staining at the
extreme surface. In non-OA grafted cartilage, no indication
of surface staining could be seen. Non-grafted OA cartilage
stained very similarly to the non-OA cartilage although
occasionally, the surface showed some positive staining,
and some deep cells showed some faint pericellular stain-
ing [Fig. 7(a)]. Grafted OA cartilage showed general posi-
tive staining of all chondrocytes and some indications in a
number of sections of positive surface staining. The matrix
showed no indication of staining except around sections of
invading vasculature where a narrow rim of the matrix
around the entire invasion stained positively [Fig. 7(b)].
This rim of positive staining was not as intense and did not
penetrate as deeply into the matrix as the type I collagen
staining.Discussion
It has been demonstrated here that human OA articular
cartilage loses its ability to remain avascular when placed
on to an active vasculature, that of the chick CAM.
Changes in the ECM components were examined by both
histochemical and immunohistochemical staining. Most
notable is the observation that vascular invasion was
always associated with a localized loss of proteoglycan/
GAG staining within the cartilage ECM and a deposition of
collagen types I and X along the rim of invasive vessels.
CAM grafting did not have any noticeable effect on the rest
of the matrix. This, however, may not be such a surprise. As
incubation time is relatively short and it is known that
cartilage ECM components have a slow turnover time
within cartilage matrix,2,21 there is unlikely to be a signifi-
cant cartilage mediated change over such a short period of
time.
446 S. A. Fenwick et al.: Osteoarthritic cartilage vascularizationFig. 3. (a) Section of a grafted piece of healthy cartilage, there is no indication of any vascular invasion in the deep layers (s indicates the
surface). (b) Section of a grafted piece of OA cartilage. Two small invasions can be seen into the deep layers (arrows) but there is no
indication of invasion through the surface layers (s) (×100).
(a)
(b)The results of this study are similar to previous studies
that have examined types I, II and X collagen and
proteoglycan/GAG in cartilage.3,24–26,28,29,40,41 Type I col-
lagen is often found confined to the surface layer of normal
cartilage. Type II collagen showed general uniform staining
throughout both control and OA cartilage sections, as
would be expected, and has been shown previously.7,29
Aigner et al.27 however, also showed some irregular
staining of type II collagen in OA cartilage, via enhancedpericellular deposition and diminished inter-territorial
staining.
Type X collagen stained to varying degrees in both OA
and non-OA cartilage at the surface layers, and in the
pericellular region of a number of the chondrocytes and
also intra-cellularly in the majority of chondrocytes. Healthy
cartilage has previously shown little or no type X collagen
staining,30,42 whilst OA cartilage has been shown to stain
for type X collagen both intra-cellularly and pericelluarly,
Osteoarthritis and Cartilage Vol. 7 No. 5 447Fig. 4. (a) Loss of metachromatic staining for proteoglycans with safranin-O around an invasive vessel (×200). (b) Loss of cartilage specific
GAG staining shown by a decrease in alcian blue CEC staining around an invasive vessel (×100) (arrows indicate the area of staining loss).
(a)
(b)most prominently around hypertrophic cells and proliferat-
ing clusters of cells in the upper and middle zones of the
cartilage.28,30
However, the most prominent feature of the staining of
the cartilage was of the invasive vessels seen in CAM
grafted OA cartilage. The rim of matrix around the
invasion stained positively for both type I collagen and
type X collagen. Type I collagen is associated with
de-differentiated chondrocytes.42–44 It is also a component
of blood vessels and is known to be upregulated in
endothelial cells undergoing angiogenesis.45 Type X has
been hypothesized to be a factor in the calcification/
mineralization and vascularization of cartilage.46–49 The
source of the type I collagen could either be cartilage
or vasculature derived as the anti-type I antibody is apolyclonal shown to cross react with both human and chick
type I. The anti-type X antibody is specific for human type X
collagen, therefore the type X collagen laid down in the
matrix must be cartilage derived.
It has been shown that the underlying subchondral bone
and the calcified cartilage between the subchondral bone
and articular cartilage contains blood capillaries,50 this is
part of the normal structure of the joint, and as such is not
a symptom of the OA process. However vascularization of
the articular cartilage above the original ‘tidemark’, a
defined layer between the calcified cartilage and the articu-
lar cartilage, is an important step in the pathological pro-
cess of OA.16 The vascularization of cartilage above this
tidemark is partly responsible for the conversion of cartilage
to bone, a process which requires a mineralized cartilage
448 S. A. Fenwick et al.: Osteoarthritic cartilage vascularizationFig. 5. (a) Surface staining for type I collagen and along the rim of an invasive vessel (s indicates the surface layer, arrow indicates the
vessel) (×40). (b) Higher power micrograph of an invasive vessel showing a rim of positive staining for type I collagen (v is the vessel, arrows
indicate type I positive staining) (×200).
(a)
(b)intermediate51 (un-mineralized cartilage is generally resist-
ant to vascularization52), there is therefore, an advance-
ment of the tidemark as the cartilage is calcified, and
subsequently eroded.4 However, in the work described
above, there was no histological evidence of cartilage
mineralization in tissue sections in any of the tissue
samples analysed, indicating that the process on the CAM
may not require the cartilage to be mineralized for vascu-
larization. The invasive process may be more like thevascularization of avian cartilage, which, during develop-
ment, is known not to mineralize before vascular
invasion.53
Alongside the cartilage erosion associated with the
pathology of OA, there is also renewed growth of cartilage
(and bone) at the joint margin, resulting in the formation
of osteophytes.2,6,54 New vasculature is required for
this process, the formation and growth of the osteophyte
being reliant upon the proliferation of blood vessels into
Osteoarthritis and Cartilage Vol. 7 No. 5 449Fig. 6. (a) Staining of cartilage with anti-type II antibody in a section of grafted OA cartilage showing an almost blanket staining effect with
some regions of only pericellular staining (indicated by arrow) (×40). (b) Intense pericellular staining for type II collagen in a section of grafted
non-OA cartilage (arrows) (×200).
(a)
(b)degenerate articular cartilage.54 The vasculature therefore,
is partly responsible for the erosion of degenerate cartilage
and the formation of new bone via endochondral ossifi-
cation, yet at the same time aids in the growth of new
cartilage within the same joint. This new cartilage appears
similar to normal articular cartilage at the histological level
(personal observation), which as such is not surprising as
the growth of osteophytes is considered to be a mechanism
of attempted repair.54
Despite its now accepted role in the OA process, carti-
lage vascularization has more commonly been associatedwith rheumatoid arthritis, an inflammatory disease
of the articular cartilage and surrounding joint. Chronic
inflammation is very much associated with angiogenesis,55
however, osteoarthritis is considered to be a non-
inflammatory disease. If OA is non-inflammatory, then the
mediators of the angiogenic response may be very different
from those associated with an inflammatory response. The
presence or absence of angiogenesis mediating cells, such
as macrophages or mast cells, needs to be assessed,
along with the presence of angiogenic factors such
as vascular endothelial growth factor (VEGF) and basic
450 S. A. Fenwick et al.: Osteoarthritic cartilage vascularizationFig. 7. (a) Faint staining of the pericellular matrix of non-grafted OA cartilage with the anti-type X antibody (short arrows), the chondrocytes
are also intensely stained (long arrows) (×100). (b) Deposition of type X collagen along the rim of an invasive vessel (arrows indicate positive
staining) (×100).
(a)
(b)fibroblast growth factor (bFGF). The role of MMP and TIMP
in the process is also of great interest, as evidence sug-
gests that cartilage turnover and degradation is mediated
by an imbalance between the activity of MMP and their
inhibitors.56,57 An examination of cartilage and vascular
derived MMP and TIMP may provide much information
about the mechanism of cartilage destruction during vas-
cular invasion, and the role that both the cartilage itself, and
the invasive vasculature play during the process.
OA cartilage has never previously been grafted onto the
CAM, therefore this work provides a novel model for
the study of active vascularization of human OA cartilage.The process of vascularization of human OA cartilage on
the CAM occurs rapidly. The study of this process is
therefore enhanced by this model which may aid in
elucidating the reasons as to why the process occurs,
along with the cell biological, biochemical and molecular
mechanisms behind the process.
In conclusion, human OA cartilage loses its avascular
state when placed onto the chick CAM. There is a loss of
non-specific and cartilage-specific GAG and proteoglycans
around the invasion site, and deposition of type I and type
X collagen along the rim of vascular invasion, which may
have a role in the process.
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